Consolidated Statement of Operations - USD ($)	3 Months Ended		9 Months Ended
	Jul. 31, 2020	Jul. 31, 2019	Jul. 31, 2020	Jul. 31, 2019
Details
Revenues	$ 2,207,722	$ 3,798,149	$ 9,611,780	$ 11,088,397
Cost of expenses:
Cost of revenues	860,540	2,137,662	5,567,720	6,206,428
Research and development expenses	66,042	143,102	281,739	426,376
Selling, general, and administrative expenses	1,272,376	2,411,029	5,733,142	7,079,287
Operating Expenses	2,198,958	4,691,793	21,456,882	13,712,091
Impairment charges			9,874,281	0
Income/(Loss) from operations	8,764	(893,644)	(11,845,102)	(2,623,694)
Interest expense - related party	238,826	180,191	667,741	515,875
Other loss	19,473	0	19,473	0
Loss before income taxes	(249,535)	(1,073,835)	(12,532,316)	(3,139,569)
Provision for income taxes	0	0	31,560	0
Net loss	$ (249,535)	$ (1,073,835)	$ (12,563,876)	$ (3,139,569)
Net loss per common share - basic	$ (0.03)	$ (0.14)	$ (1.63)	$ (0.41)
Net loss per common share - diluted	$ (0.03)	$ (0.14)	$ (1.63)	$ (0.41)
Weighted average number of common shares outstanding - basic	7,712,091	7,696,091	7,710,047	7,696,091
Weighted average number of common shares outstanding - diluted	7,712,091	7,696,091	7,710,047	7,696,091